Where is OculoMotor Technologies based?

OculoMotor Technologies is based in Newark, United States (US).

When was OculoMotor Technologies founded?

OculoMotor Technologies was founded in 2018.

How big is OculoMotor Technologies?

OculoMotor Technologies has 2-10 employees.

Is OculoMotor Technologies verified on Enterprise League?

Yes — OculoMotor Technologies's profile is verified on Enterprise League.

OculoMotor Technologies

Newark, United States (US) · Health and Medical

We built this page from public sources. What we do with your data

Do you work at OculoMotor Technologies?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

#virtual reality

#eye tracking

OculoMotor Technologies is a Newark, New Jersey-based startup revolutionizing vision care with innovative virtual reality and eye-tracking solutions for optometrists and clinicians.We empower vision professionals to deliver improved clinical outcomes and engaging therapeutic experiences to patients with binocular vision disorders.

Overview

OculoMotor Technologies is a Newark, New Jersey-based startup revolutionizing vision care with innovative virtual reality and eye-tracking solutions for optometrists and clinicians.

We empower vision professionals to deliver improved clinical outcomes and engaging therapeutic experiences to patients with binocular vision disorders. Our core offering, VERVE, is an FDA-cleared VR device specifically designed for the treatment of convergence insufficiency, while SPOT, launching in 2026, will provide a rapid screening platform for a wide range of binocular disorders.

Founded in 2018 by a team of vision scientists, engineers, and optometrists, OculoMotor Technologies leverages cutting-edge technology to transform the way vision care is delivered, making it more accessible, efficient, and enjoyable for both patients and practitioners. We are committed to advancing the field through rigorous research and development.

Visit Official Website

Most teams do this before shortlisting

Contact Details

info@oculomotortechnologies.com

Newark, United States (US), 211 Warren St

Founded

2018

Company Type

Private Limited Company

Employees

2-10

Keywords

#virtual reality

#eye tracking

Awards

• 2026 OpenSee all

Products

VERVE

Biotechnology

VERVE (Virtual Eye Rotation Vision Exercises) is a vision therapy tool for optometry practices to treat convergence insufficiency and other vergence disorders. Therapy is integrated into our VR game, and automatically adjusts in difficulty to match patient performance. Treatment requires regularly scheduled sessions , just like traditional in-office therapy — except it's much easier for the optometrist, and much more fun for the patient! VERVE is the ONLY FDA-cleared [510(k)] VR Device to treat convergence insufficiency.

N/A

Services

SPOT

Biotechnology

SPOT (Screening Patients with Oculomotor Testing) is a vision diagnostics platform that screens for 75% of binocular disorders in much less time than a full binocular vision exam. SPOT can be administered by any provider that screens for general health problems, including optometrists, physicians, pediatricians, and school nurses. We hope to launch this platform in early 2026.

N/A

Companies teams usually look at after OculoMotor Technologies

Comparing a few options usually leads to better decisions

Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.